PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1115
https://www.valueinhealthjournal.com/article/S1098-3015(12)02828-8/fulltext
Title :
PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02828-8&doi=10.1016/j.jval.2012.08.1115
First page :
A393
Section Title :
Infection
Open access? :
No
Section Order :
617